Contribution: Industrial Research Assistance Program – Contributions to Firms
ABOzymes Biomedical Inc.
$45,000.00
Development of cell lines for enzyme production, scale-up and purification
FY 2021-22 · 2021-06-16
Summary
The project will involve the development of standard operating procedures (SOP) for expression, scale up production and purification of 0.5 gram level quantity of two types blood type converting enzymes meeting Good Laboratory Practices (GLP) standards.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Vancouver|Vancouver, British Columbia, Canada
Recipient Type
For-profit organization
Business Number
706842473
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Amendments
Each version of the agreement as published, oldest first, with its total as of that version. The amount above is the latest.
| Amendment | Date | Fiscal Year | Total |
|---|---|---|---|
| 0 | 2021-06-16 | 2021-22 | $21,000.00 |
| 1 | 2021-06-16 | 2021-22 | $45,000.00 |
As published
Additional Information
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 197 days. The total amended value is 24,000 dollars.
Additional Information (French)
Cet accord a été modifié 1 fois La date de fin du présent accord a été changé de 197 jours. La valeur totale des modifications est de 24 000 dollars.
Agreement End Date
2022-06-30
Agreement Number
974580
Agreement Start Date
2021-06-16
Agreement Title
Development of cell lines for enzyme production, scale-up and purification
Agreement Title (French)
Développement de lignées cellulaires pour la production, la mise à l'échelle et la purification d'enzymes
Agreement Type
Contribution
Agreement Value
$45,000.00
Amendment Date
2021-12-18
Amendment Number
1
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
The project will involve the development of standard operating procedures (SOP) for expression, scale up production and purification of 0.5 gram level quantity of two types blood type converting enzymes meeting Good Laboratory Practices (GLP) standards.
Description (French)
Le projet comprendra l'élaboration de procédures opérationnelles standard (POS) pour la production, la mise à l'échelle et la purification d'une quantité de 0,5 gramme de deux types d'enzymes. Ces enzymes de conversion du groupe sanguin répondent aux normes des bonnes pratiques de laboratoire (BPL).
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Vancouver Centre
Federal Riding (French)
Vancouver-Centre
Federal Riding Number
59034
NAICS Code
541710
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
706842473
Recipient City
Vancouver|Vancouver
Recipient Country
CA
Recipient Legal Name
ABOzymes Biomedical Inc.
Recipient Postal Code
V7X 1L3
Recipient Province or Territory
BC
Recipient Type
F
Reference Number
172-2021-2022-Q2-974580
